Conversion from Tacrolimus IR (Twice Daily) or Cyclosporine to Tacrolimus XR (Envarsus®, Once Daily) in Lung Transplant Recipients.
JOURNAL OF HEART AND LUNG TRANSPLANTATION(2020)
摘要
In our cohort, LCP-Tac was safe in lung transplant recipients at various time points after LT. CF patients required significantly numerically higher total daily weight based dosing compared to non-CF LT recipients, despite lower trough levels.
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络